Safety and immunogenicity of the synthetic carbohydrate conjugate vaccine, SF2a-TT15, against Shigella flexneri 2a in infants in Kenya: a phase 2a, age-descending, dose-escalating, double-blind, randomised, placebo-controlled study. (linkinghub.elsevier.com)

Authors: Sawe F … Phalipon A Journal: Lancet Infectious Diseases Published: 2026-08-19 DOI: https://doi.org/10.1016/S1473-3099(26)00307-5